The University of Florida was awarded a $681,958 federal Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant, titled "University of Florida Partnerships Across Interdisciplinary Networks: Training through Engineering, Epidemiology & Addiction Medicine (UF PAIN TEAM)", aims to train the next generation of independent clinical pain researchers through an interdisciplinary...
This $242,061 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279) establishes an interdisciplinary clinical pain research training program at Mass General Brigham (MGB) in Boston. The program will support 8-12 postdoctoral fellows over 5 years, providing protected research time and dedicated training to expand the pool of early-career investigators capable of launching successful clinical...
This federal Project Grant award in the amount of $351,097 was provided by the National Institute of Neurological Disorders and Stroke (NINDS), which is part of the National Institutes of Health (NIH). The grant was awarded under the NIH's Drug Use and Addiction Research Programs (CFDA 93.279) to establish a rigorous and supportive interdisciplinary training program in clinical pain research at Mass General Brigham (MGB) in Boston. The program will support a diverse pool of 8 postdoctoral...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $351,851 to Stanford University to establish an interdisciplinary postdoctoral training program in clinical pain research, with a focus on maternal and childhood pain. The program aims to train five fellows per year over a period of 5 years, providing mentorship and research opportunities in areas such as bioinformatics,...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $290,312 to The Washington University in St. Louis to develop a postdoctoral training program called "Promoting Excellence through Pain and Addiction Research Enhancement (PREPARE)". The PREPARE program aims to recruit and train early career investigators to conduct clinical research on the intersection of...
This $366,377 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the CFDA 93.279 Drug Use and Addiction Research Programs will fund an interdisciplinary postdoctoral training program in clinical pain research focused on maternal and childhood pain at Stanford University. The 5-year program will train up to 5 fellows per year in areas including bioinformatics, pain across the lifespan, non-pharmacological interventions, prevention of acute to...
This federal Project Grant award, identified as T90NR021683, was provided by the National Institute of Neurological Disorders and Stroke under the Drug Use and Addiction Research Programs (CFDA 93.279). The $172,596 award will support a postdoctoral training program titled "Promoting Excellence through Pain and Addiction Research Enhancement (PREPARE)" at the Washington University in St. Louis. The key objectives of the PREPARE program are to: 1) recruit and train early career...
The University of Utah was awarded a $752,453 Project Grant by the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279) to support the University of Utah Program to Provide Pain Research Knowledge (UP3RK). The UP3RK program aims to train an interdisciplinary pool of well-trained clinical pain research scientists to address the nation's biomedical, behavioral, and clinical pain research needs. The program will provide...
The University of Utah was awarded a $698,670 Project Grant by the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279) on August 15, 2024. The grant, titled the "University of Utah Program to Provide Pain Research Knowledge (UP3RK)", aims to prepare an interdisciplinary group of well-trained clinical pain research scientists to address the nation's biomedical, behavioral, and clinical pain research needs. Over...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to study the role of GTP cyclohydrolase 1 (GCH1) in chronic orofacial neuropathic pain and its potential as a therapeutic target. The $838,750 award will support research at the University of Florida to investigate whether inhibiting GCH1 can alleviate nerve injury-induced pain responses and alter related monoamine levels in the...
The University of Florida was awarded a $362,689 Project Grant by the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279). The award titled "University of Florida Partnerships Across Interdisciplinary Networks: Training through Engineering, Epidemiology & Addiction Medicine (UF PAIN TEAM)" will establish an interdisciplinary postdoctoral training program to develop the next generation of independent clinical pain researchers. The program will provide extensive team-based training across disciplines traditionally and not traditionally represented in pain research, with the goal of equipping trainees with new skills, knowledge, and expertise to conduct collaborative, team-based clinical pain research. The 5-year program will support 4 postdoctoral fellows (T90) and 1 non-citizen, non-permanent resident clinically-trained PhD holder (R90) seeking advanced training in high priority HEAL research areas such as pain across the lifespan, non-pharmacological interventions, and advancing health equity in pain.